Page 162 - Haematologica June

A. Desai et al.
Primary hypertrophic osteoarthropathy with digital clubbing and palmoplantar hyperhidrosis caused by 15-PGHD/HPGD loss-of-function mutations. Exp Dermatol. 2011;20(6):531-533.
28. Diggle CP, Carr IM, Zitt E, et al. Common and recurrent HPGD mutations in Caucasian individuals with primary hyper- trophic osteoarthropathy. Rheumatology (Oxford). 2010;49(6):1056-1062.
29. Erken E, Koroglu C, Yildiz F, Ozer HT, Gulek B, Tolun A. A novel recessive 15-hydroxy- prostaglandin dehydrogenase mutation in a family with primary hypertrophic osteoarthropathy. Mod Rheumatol. 2015;25(2):315-321.
30. Sinibaldi L, Harifi G, Bottillo I, et al. A novel homozygous splice site mutation in the HPGD gene causes mild primary hyper- trophic osteoarthropathy. Clin Exp
Rheumatol. 2010;28(2):153-157.
31. Uppal S, Diggle CP, Carr IM, et al. Mutations
in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropa- thy. Nat Genet. 2008;40(6):789-793.
32. Yuksel-Konuk B, Sirmaci A, Ayten GE, et al. Homozygous mutations in the 15-hydroxy- prostaglandin dehydrogenase gene in patients with primary hypertrophic osteoarthropathy. Rheumatol Int. 2009; 30(1):39-43.
33. Diggle CP, Parry DA, Logan CV, et al. Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis. Hum Mutat. 2012;33(8):1175-1181.
34. Lilenbaum R, Socinski MA, Altorki NK, et al. Randomized phase II trial of docetaxel/ irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer. J
Clin Oncol. 2006;24(30):4825-4832.
35. El-Rayes BF, Zalupski MM, Manza SG, et al. Phase-II study of dose attenuated sched- ule of irinotecan, capecitabine, and cele- coxib in advanced colorectal cancer. Cancer Chemother Pharmacol. 2008;61(2):
283-289.
36. Davies JM, Goldberg RM. First-line thera-
peutic strategies in metastatic colorectal can- cer. Oncology (Williston Park). 2008;22(13): 1470-1479.
37. Maiello E, Giuliani F, Gebbia V, et al. FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM). Ann Oncol. 2006;17(Suppl 7):vii55-59.
38. Markowitz SD. Aspirin and colon cancer-- targeting prevention? N Engl J Med. 2007;356(21):2195-2198.
1064
haematologica | 2018; 103(6)